Canadian Natural Resources' strategy involves a 7.9% production boost in 2024, consistent reserves, share buybacks, and ...

Coinbase saw Q2 gains from crypto volatility and derivatives growth, but policy shifts may bring mixed effects on trading.

AbbVie has delivered strong returns and dividend growth, with solid prospects but notable risks creating near-term ...

Invest smartly during the FIFA World Cup! Learn how a balanced Nike and Adidas split outperforms the S&P 500, leveraging ...

LB Pharmaceuticals (LBRX), a New York-based drug developer focused on neuropsychiatric diseases, such as schizophrenia, has ...

Interest in Southeast Asia continues to increase amid shifting global supply chains, elevated geopolitical risks in China, ...

ZIM's mixed H2'25 outlook offers insights on share prices, dividends, and potential privatization. Read more on why we have ...